These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2379163)

  • 1. Presence of cell lineage-specific hypomethylated sites in the major breakpoint cluster region.
    Litz CE; Goldfarb AN; Strickler JG; Brunning RD
    Cancer Res; 1990 Aug; 50(16):4984-90. PubMed ID: 2379163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
    Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation status of the major breakpoint cluster region in Philadelphia chromosome negative leukemias.
    Litz CE; McClure JS; Coad JE; Goldfarb AN; Brunning RD
    Leukemia; 1992 Jan; 6(1):35-41. PubMed ID: 1346543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    O'Brien S; Kantarjian H; Shtalrid M; Blick M; Beran M; Talpaz M
    Hematol Pathol; 1988; 2(1):25-9. PubMed ID: 3235381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region.
    Ge XQ; Tanaka K; Mansyur A; Tazawa H; Iwato K; Kyo T; Dohy H; Kamada N
    Cancer Genet Cytogenet; 2001 Apr; 126(2):102-10. PubMed ID: 11376802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal nature of Philadelphia chromosome-positive and -negative chronic myelogenous leukemia by DNA hybridization analyses.
    Yoffe G; Chinault AC; Talpaz M; Blick MB; Kantarjian HM; Taylor K; Spitzer G
    Exp Hematol; 1987 Aug; 15(7):725-8. PubMed ID: 2440709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK; Minden MD
    Biochem Biophys Res Commun; 1997 May; 234(3):742-7. PubMed ID: 9175786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK; Minden MD
    Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities.
    Lukásová E; Koristek Z; Falk M; Kozubek S; Grigoryev S; Kozubek M; Ondrej V; Kroupová I
    J Leukoc Biol; 2005 Jan; 77(1):100-11. PubMed ID: 15507473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
    Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach to clonality analysis. Alterations in genomic methylation of Epstein-Barr virus transformed lymphocytes.
    Goldfarb AN; Litz CE
    Pathol Res Pract; 1993 Apr; 189(3):312-5. PubMed ID: 8392725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human erg gene maps to chromosome 21, band q22: relationship to the 8; 21 translocation of acute myelogenous leukemia.
    Rao VN; Modi WS; Drabkin HD; Patterson D; O'Brien SJ; Papas TS; Reddy ES
    Oncogene; 1988 Nov; 3(5):497-500. PubMed ID: 3274086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction fragment length polymorphism of bcr in Japanese patients with hematological malignancies.
    Kato Y; Sawada H; Tashima M; Yumoto Y; Okuda T; Ueda T; Uchino H; Hotta T; Mitsutani S; Ono T
    Leukemia; 1988 Oct; 2(10):701-3. PubMed ID: 2902258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
    Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
    Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
    Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
    Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring normal and malignant human white blood cells by the use of linear programmed thermal degradation mass spectrometry.
    Yergey AL; Risby TH; Golomb HM
    Biomed Mass Spectrom; 1978 Jan; 5(1):47-51. PubMed ID: 272206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.